Knapp Thomas J 4
4 · Sucampo Pharmaceuticals, Inc. · Filed May 4, 2011
Insider Transaction Report
Form 4
Transactions
- Award
Employee Stock Option (Right to buy)
2011-05-02+14,400→ 14,400 totalExercise: $4.41Exp: 2021-05-02→ Class A common stock (14,400 underlying) - Award
Employee Stock Option (Right to buy)
2011-05-02+106,250→ 106,250 totalExercise: $4.41Exp: 2021-05-02→ Class A common stock (106,250 underlying)
Footnotes (2)
- [F1]Commencing on May 2, 2012, the first anniversary of the original grant date, the option vests annually with respect to 25% of the aggregate option share total.
- [F2]Performance Conditions for vesting: 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $8/sh = 42,500; 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $12/sh = 42,500; and 20% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $16/sh = 21,250.